822 related articles for article (PubMed ID: 19560804)
1. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
[No Abstract] [Full Text] [Related]
2. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D
J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
[No Abstract] [Full Text] [Related]
4. Immunotherapy for Hymenoptera venom allergy compared with real-life stings: Are we doing our best?
Pecoraro L; Giovannini M; Mori F; Saretta F; Barni S; Castagnoli R; Arasi S; Mastrorilli C; Liotti L; Caminiti L; Novembre E;
Clin Exp Allergy; 2021 Feb; 51(2):209-211. PubMed ID: 33617014
[No Abstract] [Full Text] [Related]
5. [Results of hyposensitization with bee and wasp venom].
Adolph J; Dehnert I; Fischer JF; Wenz W
Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
[TBL] [Abstract][Full Text] [Related]
6. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
8. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of allergy to hymenoptera venoms.
Hamilton RG
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
11. The sting challenge test in Hymenoptera venom allergy: pros and cons.
Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
[TBL] [Abstract][Full Text] [Related]
14. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
Goldberg A; Yogev A; Confino-Cohen R
Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
Müller UR; Golden DB; Demarco PJ; Lockey RF
Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
[No Abstract] [Full Text] [Related]
16. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
17. [Renal complications due to desensitization].
Drouet M; Sabbah A; Bonneau JC; Le Sellin J
Allerg Immunol (Paris); 1986 Apr; 18(4):17-9. PubMed ID: 3453713
[TBL] [Abstract][Full Text] [Related]
18. [Allergy to bee and yellow jacket venoms].
Saari S; Kalimo K; Viander M; Henriksson S
Duodecim; 1985; 101(4):393-401. PubMed ID: 3979324
[No Abstract] [Full Text] [Related]
19. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
20. Venom immunotherapy: pitfalls and open questions.
Aberer W; Sturm G
Immunotherapy; 2011 Nov; 3(11):1277-9. PubMed ID: 22053877
[No Abstract] [Full Text] [Related]
[Next] [New Search]